CN107252116A - A kind of complex health care product of relieving mental strain and helping sleep - Google Patents
A kind of complex health care product of relieving mental strain and helping sleep Download PDFInfo
- Publication number
- CN107252116A CN107252116A CN201710481063.7A CN201710481063A CN107252116A CN 107252116 A CN107252116 A CN 107252116A CN 201710481063 A CN201710481063 A CN 201710481063A CN 107252116 A CN107252116 A CN 107252116A
- Authority
- CN
- China
- Prior art keywords
- health care
- care product
- oil
- complex health
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036541 health Effects 0.000 title claims abstract description 30
- 230000003340 mental effect Effects 0.000 title claims abstract description 15
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 50
- 239000003921 oil Substances 0.000 claims abstract description 33
- 235000019198 oils Nutrition 0.000 claims abstract description 33
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 30
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 30
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 30
- 235000019498 Walnut oil Nutrition 0.000 claims abstract description 29
- 239000008170 walnut oil Substances 0.000 claims abstract description 29
- 235000015463 Lycium carolinianum Nutrition 0.000 claims abstract description 25
- 240000000924 Lycium carolinianum Species 0.000 claims abstract 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 26
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 18
- 239000002253 acid Substances 0.000 claims description 18
- 150000002617 leukotrienes Chemical class 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 16
- 229930003427 Vitamin E Natural products 0.000 claims description 13
- 239000002775 capsule Substances 0.000 claims description 13
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 13
- 239000011709 vitamin E Substances 0.000 claims description 13
- 235000019165 vitamin E Nutrition 0.000 claims description 13
- 229940046009 vitamin E Drugs 0.000 claims description 13
- 238000000227 grinding Methods 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 10
- 108010010803 Gelatin Proteins 0.000 claims description 9
- 229920000159 gelatin Polymers 0.000 claims description 9
- 239000008273 gelatin Substances 0.000 claims description 9
- 235000019322 gelatine Nutrition 0.000 claims description 9
- 235000011852 gelatine desserts Nutrition 0.000 claims description 9
- 235000011187 glycerol Nutrition 0.000 claims description 9
- 239000008213 purified water Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- 235000020778 linoleic acid Nutrition 0.000 claims description 6
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 6
- 239000007901 soft capsule Substances 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 4
- 239000005642 Oleic acid Substances 0.000 claims description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 4
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 4
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 claims description 4
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 claims description 4
- 229910052732 germanium Inorganic materials 0.000 claims description 4
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 claims description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 235000020664 gamma-linolenic acid Nutrition 0.000 claims description 3
- 229960002733 gamolenic acid Drugs 0.000 claims description 3
- 238000000465 moulding Methods 0.000 claims description 3
- 239000011669 selenium Substances 0.000 claims description 3
- 229910052711 selenium Inorganic materials 0.000 claims description 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 2
- 229960004488 linolenic acid Drugs 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims 1
- 235000007586 terpenes Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 19
- 210000004369 blood Anatomy 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 12
- 239000000463 material Substances 0.000 abstract description 12
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 6
- 229910052760 oxygen Inorganic materials 0.000 abstract description 6
- 239000001301 oxygen Substances 0.000 abstract description 6
- 229940088594 vitamin Drugs 0.000 abstract description 6
- 229930003231 vitamin Natural products 0.000 abstract description 6
- 235000013343 vitamin Nutrition 0.000 abstract description 6
- 239000011782 vitamin Substances 0.000 abstract description 6
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 6
- 210000003734 kidney Anatomy 0.000 abstract description 5
- 210000004204 blood vessel Anatomy 0.000 abstract description 4
- 230000000517 effect on sleep Effects 0.000 abstract description 4
- 210000000987 immune system Anatomy 0.000 abstract description 4
- 210000004185 liver Anatomy 0.000 abstract description 4
- 230000003860 sleep quality Effects 0.000 abstract description 4
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 abstract description 3
- 230000002457 bidirectional effect Effects 0.000 abstract description 3
- 230000008030 elimination Effects 0.000 abstract description 3
- 238000003379 elimination reaction Methods 0.000 abstract description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 abstract description 3
- 230000003213 activating effect Effects 0.000 abstract description 2
- 244000241838 Lycium barbarum Species 0.000 description 27
- 230000000052 comparative effect Effects 0.000 description 20
- 240000007049 Juglans regia Species 0.000 description 10
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 9
- 239000003513 alkali Substances 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 206010022437 insomnia Diseases 0.000 description 8
- 235000009496 Juglans regia Nutrition 0.000 description 7
- 239000011149 active material Substances 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 238000011084 recovery Methods 0.000 description 7
- 235000020234 walnut Nutrition 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 6
- 241000256856 Vespidae Species 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 239000010779 crude oil Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000000638 solvent extraction Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 229940094952 green tea extract Drugs 0.000 description 2
- 235000020688 green tea extract Nutrition 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 206010003084 Areflexia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- RDMQPKIDHAFXKA-JNORPAGFSA-N Ganoderic Acid Am1 Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC(=O)C1=C2C(=O)C[C@]2(C)[C@@H]([C@@H](CC(=O)CC(C)C(O)=O)C)CC(=O)[C@]21C RDMQPKIDHAFXKA-JNORPAGFSA-N 0.000 description 1
- 229930182735 Ganoderic acid Natural products 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 235000017784 Mespilus germanica Nutrition 0.000 description 1
- 244000182216 Mimusops elengi Species 0.000 description 1
- 235000000560 Mimusops elengi Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 235000007837 Vangueria infausta Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000004720 cerebrum Anatomy 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 229940098330 gamma linoleic acid Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004491 retinal development Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000028527 righting reflex Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-N sodium;5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)NC1=O QGMRQYFBGABWDR-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/02—Pretreatment
- C11B1/04—Pretreatment of vegetable raw material
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/10—Production of fats or fatty oils from raw materials by extracting
- C11B1/104—Production of fats or fatty oils from raw materials by extracting using super critical gases or vapours
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B3/00—Refining fats or fatty oils
- C11B3/001—Refining fats or fatty oils by a combination of two or more of the means hereafter
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides a kind of complex health care product of relieving mental strain and helping sleep.A kind of complex health care product of relieving mental strain and helping sleep, is mainly made up of following component:By weight, 200 500 parts of walnut oil, 100 300 parts of spine date seed oil, 40 100 parts of Boxthorn Seed Oil, 20 70 parts of ganoderma lucidum spore oil, 0 20 parts of vitamin e1.The coordinated that the complex health care product of the present invention passes through various materials, start with from multiple dimensions such as blood, blood vessel, activating immune system, elimination superoxide radical, the oxygen-enriched ability of offer, immune bidirectional modulation, calmness, liver protecting and kidney invigoratings, comprehensive the eliminate the effects of the act physiology of sleep quality and the undesirable element of psychological aspects, improve sleep quality, play significant relieving mental strain and helping sleep effect.
Description
Technical field
The present invention relates to health product technology field, more particularly, to a kind of complex health care product of relieving mental strain and helping sleep.
Background technology
Insomnia refers to that patient is unsatisfactory on the length of one's sleep or quality and influences a kind of subjective experience of social function in the daytime.It is existing
There is limitation to the understanding of insomnia in clinical medicine science, generally lack the clear and definite cause of disease, or excluding possible cause insomnia
Insomnia is still left after the cause of disease, mainly including Psychophysiological insomnia, idiopathic insomnia, subjective insomnia and part physiology
Property disease caused by have a sleepless night.Research is it is also shown that insomnia caused by physiological disorder is closely related with hypoimmunity.But no matter
Any insomnia, is required for very long therapeutic process, and easily recurs, and therefore, early stage active prevention is extremely important.With existing
For the quickening of social rhythm, people pay attention to sleep-assistant health care further, but still are limited to simple dietotherapy at present, have little effect.Therefore,
It is that this area is urgently to be resolved hurrily to improve the quality of life of people there is provided the health products of the more preferable relieving mental strain and helping sleep of new, effect
A technical problem.
In view of this, it is special to propose the present invention.
The content of the invention
It is an object of the invention to provide a kind of complex health care product of relieving mental strain and helping sleep, described complex health care product utilizes science
Compatibility relationship, with more significant relieving mental strain and helping sleep and improve immunity effect, and it is natural to draw materials, without any toxicity and side effects.
In order to realize the above object the invention provides following technical scheme:
A kind of complex health care product of relieving mental strain and helping sleep, is mainly made up of following component:By weight,
Wherein, walnut oil contains abundant squalene, Flavonoid substances and polyphenolic substance.Squalene can promote blood to follow
Ring, activates physical function cell, anti-inflammation and sterilization, repair cell;Flavonoid substances and polyphenolic substance can strengthen the expansion of blood vessel
Ability, regulation blood fat, reduction cholesterol and blood glucose, improves blood vessel microcirculation, protects cell not by radical damage, improves comprehensively
Immunity.Walnut oil also has regulation body's cholesterol, cerebrum tonifying, promotes retinal development and promote bone growth, improve sleep.Separately
Nutritional ingredient in outer walnut oil, have effects that to invigorate the kidney and stop nocturnal emission, the diuresis that helps digestion, warm lung Dingchuan.
Spine date seed oil contains various trace elements, vitamin C and the plants such as 17 kinds of amino acid, potassium, calcium, sodium, zinc, iron, copper, manganese
Thing sterol etc..Its active ingredient promotes liver cell regeneration and protects liver cell, antifatigue, improves immune function of human body, promotes blood
Liquid cyclic activation physical function cell, can be effectively improved neurasthenia, calmness, improve sleep, brain healthy prevention senile dementia
Disease.
Boxthorn Seed Oil contains abundant and comprehensive bioactive substance and oleic acid, linoleic acid, gamma linoleic acid, β carrots
Element, SOD etc..Boxthorn Seed Oil has obvious effect to regulation blood fat, liver-nourishing and eyesight-improving, kidney tonifying anticancer.
The triterpenes ganoderic acid that ganoderma lucidum spore oil contains has strong pharmacological activity, has protect liver, removing toxic substances, kills cancer cell
And pain-relieving functions.Unrighted acid that ganoderma lucidum spore oil contains can pre- preventing thrombosis and artery sclerosis, reduce malignant cholesterol, net
Change blood and eliminate free radical.The organic germanium that ganoderma lucidum spore oil contains has decompression, diuresis, analgesic effect, induces and promotes huge
The phagocytosis of phagocyte.Ganoderma lucidum spore oil suppresses the propagation of tumour cell by activated NK, and can be with bidirectional modulation
The immune system of human body.
Vitamin E is that life continues one of required nutrient.It can promote sex hormone to secrete, and improve fecundity, protect
T lymphocytes, protection red blood cell, Green Tea Extract oxidation are protected, the lipid peroxidation reaction in ocular lens body can be suppressed, make peripheral blood
Enlargement of pipe, improves blood circulation.
The present invention five kinds of compositions from more than, the proportioning composition complex health care product through science, on the basis of strengthen immunity
On, it can not only reach not introduce in relieving mental strain and helping sleep effect more significant than existing health products, and the formula of the present invention and appoint
The medicinal material or auxiliary material of what toxic side effect, therefore be used for a long time safer.
There is the effect of stronger improvement blood microcirculation and activation body function cell in the present invention, in walnut oil, and
And improve sleep with spine date seed oil collocation, prevent senile dementia;Boxthorn Seed Oil is except that can remove the rubbish in blood, moreover it is possible to subtract
Few vascular wall cholesterol deposition, prevents the SOD contained in blood fat atherosclerosis, Boxthorn Seed Oil, is assisted together with vitamin E
Make, the effect with very strong elimination superoxide radical, while cooperateing with the effect for playing liver protecting and kidney invigorating with spine date seed oil;With coker
Peach oil, Boxthorn Seed Oil and spine date seed oil three's synergic adjustment blood fat thrombus;Active component in ganoderma lucidum spore oil can be with two-way tune
The immune system of human body is saved, it cooperates with Green Tea Extract to aoxidize with vitamin E.It can be seen that, in the Halth-care composition that the present invention is provided,
The emphasis of each component is different, but by the coordinated of various materials, from blood, blood vessel, activating immune system, elimination
Multiple dimensions such as superoxide radical, the oxygen-enriched ability of offer, immune bidirectional modulation, calmness, liver protecting and kidney invigorating are started with, and are eliminated the effects of the act comprehensively
The physiology of sleep quality and the undesirable element of psychological aspects, improve sleep quality, play significant relieving mental strain and helping sleep effect.
Formula can also further optimize above, to obtain more preferable relieving mental strain and helping sleep effect, and for example formula is:By weight
Meter,
Oily composition has a major impact to the health-care effect of formula in all formulas described above, in order to improve health care effect
The oil of fruit preferably following quality:
Preferably, the walnut oil contains following component:Weight percentage,
Unrighted acid >=93%, leukotrienes Ω 3 >=15% and leukotrienes Ω 6 >=56%.
The unrighted acid includes leukotrienes Ω 3 and leukotrienes Ω 6;The accountings of leukotrienes Ω 3 refer to leukotrienes Ω 3
The proportion of walnut oil is accounted for, the accountings of leukotrienes Ω 6 refer to the proportion that leukotrienes Ω 6 accounts for walnut oil.
The oil of the quality can be through ultramicro grinding, CO2Supercritical extract, degumming, depickling are prepared from, the supercritical extract
The temperature that method is used is 20-40MPa for 25-35 DEG C, pressure.
In the present invention, walnut oil is after ultramicro grinding, and the particle diameter of walnut kernel powder is less than 100 μm, and powder diameter is uniform, carefully
Cell wall is broken, surface area and porosity increase, afterwards by CO2Supercritical extract, CO2The temperature that supercritical extraction is used
For normal temperature, walnut is in CO2Atmosphere in, should under the conditions of can ensure that the active component in walnut is particularly thermally sensitive work
Property material and oxidizable active material do not degraded by high-temperature oxygen, and the recovery rate of active component is high, obtained core
Peach oil quality is good.
Preferably, the spine date seed oil contains following component:Weight percentage,
Total saposins >=0.42 ‰, oleic acid >=49%, linoleic acid >=26% and vitamin E >=0.27 ‰.
The oil of the quality can be through ultramicro grinding, CO2Supercritical extract, degumming, depickling are prepared from, the supercritical extract
The temperature that method is used is 20-40MPa for 25-35 DEG C, pressure.
In the present invention, spina date seed is after ultramicro grinding, and the particle diameter of Spine Date Seed is less than 100 μm, and powder diameter is uniform, carefully
Cell wall is broken, surface area and porosity increase, afterwards by CO2Supercritical extract, CO2The temperature that supercritical extraction is used
For normal temperature, spina date seed is in CO2Atmosphere in, should under the conditions of can ensure that the active component in spina date seed is particularly temperature sensitive
Active material and oxidizable active material do not degraded by high-temperature oxygen, and the recovery rate of active component is high, obtains
Spine date seed oil quality better.
There is low recovery rate, dissolvent residual, active component in squeezing, the organic solvent extraction of routine, and
CO of the present invention2Supercritical extraction process completely avoid problem above.
Preferably, the Boxthorn Seed Oil includes following component:Weight percentage, linoleic acid >=61.5%, α-Asia
Numb acid >=3.1%, gamma-Linolenic acid >=3.0%, vitamin E >=0.452% and selenium >=0.44/100000.
The Boxthorn Seed Oil of the quality can be through ultramicro grinding, CO2Supercritical extract, degumming, depickling are prepared from, described super to face
The temperature that boundary's extraction is used is 20-40MPa for 25-35 DEG C, pressure.
In the present invention, matrimony vine seed is after ultramicro grinding, and the particle diameter at matrimony vine seed powder end is less than 100 μm, and powder diameter is uniform, carefully
Cell wall is broken, surface area and porosity increase, afterwards by CO2Supercritical extract, CO2The temperature that supercritical extraction is used
For normal temperature, matrimony vine seed is in CO2Atmosphere in, should under the conditions of can ensure that the active component in matrimony vine seed is particularly temperature sensitive
Active material and oxidizable active material do not degraded by high-temperature oxygen, and the recovery rate of active component is high, obtains
Boxthorn Seed Oil quality better.There is low recovery rate, dissolvent residual, active component destructible in squeezing, the organic solvent extraction of routine
The problems such as, and CO of the present invention2Supercritical extraction process completely avoid problem above.
Preferably, the ganoderma lucidum spore oil includes following component:Triterpenes aliphatic acid, unrighted acid, organic germanium and
GL-B.
The ganoderma lucidum spore oil of the quality is through ultramicro grinding, CO2Supercritical extract, degumming, depickling are prepared from, described super to face
The temperature that boundary's extraction is used is 20-40MPa for 25-35 DEG C, pressure.
In the present invention, Reishi sporule is after ultramicro grinding, and the particle diameter of Reishi sporule powder is less than 100 μm, and powder diameter is equal
Even, cell membrane is broken, surface area and porosity increase, afterwards by CO2Supercritical extract, CO2What supercritical extraction was used
Temperature is normal temperature, and Reishi sporule is in CO2Atmosphere in, should under the conditions of can ensure in Reishi sporule active component be particularly pair
Temperature sensitive active material and oxidizable active material are not degraded by high-temperature oxygen, and the recovery rate of active component
Height, obtained ganoderma lucidum spore oil quality better.
There is low recovery rate, dissolvent residual, active component in squeezing, the organic solvent extraction of routine, and
CO of the present invention2Supercritical extraction process completely avoid problem above.
Above, degumming, depickling for example can add alkali depickling (to determine alkali number, plus alkali with crude oil acid value using conventional means
Need to stir 10 minutes with 90rpm speed afterwards), heating is needed in deacidification, and heating rate preferably is 1 DEG C/min.
For formulation, although the present invention can be made into the formulations such as tablet, pill, paste or capsule in theory, but be due to
The main component of the present invention is oils, therefore, is advisable with soft capsule, its absorptivity and stability are higher.
The capsule shells that soft capsule of the prior art is used are generally the formula containing pigment, but pigment is in the presence of more or less
Side effect, therefore, the invention provides following capsule shells formula:By weight,
200-500 parts of gelatin,
150-300 parts of glycerine,
250-500 parts of purified water.
Compared with prior art, capsule shells of the invention formula is simpler, safe., can if considering lucifuge demand certainly
To solve by other means, for example, change the color of outer packing, so both met lucifuge needs, and turn avoid introducing pigment
Deng hypotoxicity raw material.As example, if any other side demand, then as far as possible not to edible part addition exogenous material, and
It is improved on packing.
In the formula of above-mentioned capsule shells, the content of each composition can also be improved further, to improve stability, for example:
Gelatin is preferred 400-500 parts, and glycerine is preferred 150-200 parts, and purified water is preferred 400-500 parts.
The capsule shells can use following preparation method:First glycerine, purified water are mixed, gained mixture after gelatin is added
Stirred 1-2 hours at 65-75 DEG C, then stand 2-3 hours, cast molding afterwards obtains rubber, is molded using capsule machine pelleting.
To sum up, compared with prior art, the present invention achieves following technique effect:
(1) by walnut oil, spine date seed oil, Boxthorn Seed Oil, five kinds of composition scientific compatibilities of ganoderma lucidum spore oil and vitamin E, reach
To significant relieving mental strain and helping sleep and raising immunity effect;
(2) pigment conventional in capsule shells is removed, the security of health products is improved;
(3) by improving CO2The operating condition of supercritical extraction process, is improved to walnut oil, spine date seed oil, matrimony vine seed
The extraction yield of oil and ganoderma lucidum spore oil, and avoid a series of problems introduced caused by the material such as organic solvent and (for example go
Except solvent cost, blowdown flow rate, dissolvent residual etc.), especially effectively prevent the oxidation and loss of heat-sensitive materials, resulting product
Advantage in terms of curative effect and stability is more prominent.
Embodiment
Technical scheme is clearly and completely described below in conjunction with embodiment, but ability
Field technique personnel will be understood that following described embodiment is a part of embodiment of the invention, rather than whole embodiments,
The present invention is merely to illustrate, and is not construed as limiting the scope of the present invention.Based on the embodiment in the present invention, the common skill in this area
The every other embodiment that art personnel are obtained under the premise of creative work is not made, belongs to the model that the present invention is protected
Enclose.Unreceipted actual conditions person in embodiment, the condition advised according to normal condition or manufacturer is carried out.Agents useful for same or instrument
Unreceipted production firm person, is the conventional products that can be obtained by commercially available purchase.
Embodiment 1
Walnut oil is extracted from walnut kernel:
1st, pre-process:Walnut kernel is cleaned, dust and other impurity is screened out.
2、CO2Supercritical extract:Temperature be 25 DEG C, pressure be to extract once under conditions of 30MPa or so, collect respectively
Oil and the dregs of fat.
3rd, degumming, depickling:Plus alkali depickling, determine to need after alkali number, plus alkali with crude oil acid value to stir 10 with 90rpm speed
Minute, heated in deacidification with 1 DEG C/min heating rates.
As a result:
Gained walnut oil contains following component:Weight percentage,
Unrighted acid is that 93.5%, leukotrienes Ω 3 is 15% and leukotrienes Ω 6 is 56.5%;The unsaturated lipid
Fat acid includes leukotrienes Ω 3 and leukotrienes Ω 6.
Embodiment 2
Walnut oil is extracted from walnut kernel:
1st, pre-process:Walnut is cleaned, dust and other impurity is screened out.
2、CO2Supercritical extract:Be in temperature, 35 DEG C, pressure be 20MPa under conditions of extract once, respectively collect oil
And the dregs of fat.
3rd, degumming, depickling:Plus alkali depickling, determine to need after alkali number, plus alkali with crude oil acid value to stir 10 with 90rpm speed
Minute, heated in deacidification with 1 DEG C/min heating rates.
Gained walnut oil contains following component:Weight percentage,
Unrighted acid is that 93%, leukotrienes Ω 3 is 15.1% and leukotrienes Ω 6 is 56%;
Embodiment 3
Ganoderma lucidum spore oil is extracted from Reishi sporule:
Step and condition be the same as Example 1.
The composition of detection gained ganoderma lucidum spore oil is more containing triterpenes aliphatic acid, unrighted acid, organic germanium and ganoderma lucidum
Sugar.
Embodiment 4
Prepare spine date seed oil:
Step and condition be the same as Example 1.
Gained spine date seed oil contains following component:By weight,
Total saposins 0.42 ‰, oleic acid 49%, linoleic acid 26% and vitamin E 0.27 ‰.
Embodiment 5
Prepare Boxthorn Seed Oil:
Step and condition be the same as Example 1.
The component content of detection gained Boxthorn Seed Oil, it is as a result as follows:
By weight percentage, linoleic acid 61.5%, alpha-linolenic acid 3.1%, gamma-Linolenic acid 3.0%, vitamin
E0.452% and selenium 0.44/100000.
Embodiment 6
Prepare capsule shells:
1st, feeding:Gelatin 400g, glycerine 200g, purified water 250g.
2nd, prepare:First glycerine, purified water are mixed, gained mixture after gelatin is added and is stirred 2 hours at 65 DEG C, then it is quiet
Put 2 hours, cast molding afterwards obtains rubber, be molded using capsule machine pelleting.
Embodiment 7
From embodiment 6 to differ only in formula different, be:Gelatin 500g, glycerine 150g, purified water 500g.
Embodiment 8
From embodiment 6 to differ only in formula different, be:Gelatin 400g, glycerine 200g, purified water 300g.
Embodiment 9
Prepare complex health care product:
1st, draw materials:Walnut oil 400g, spine date seed oil 150g, Boxthorn Seed Oil 70g, ganoderma lucidum spore oil 50g, vitamin e1 0g.
2nd, capsule is prepared:All raw materials in 1st step are mixed, homogeneous, in the capsule shells that the offer of embodiment 8 is provided.
Embodiment 10
It is different from the proportioning for differing only in primary raw material of embodiment 9, i.e. walnut oil, spine date seed oil, Boxthorn Seed Oil, spirit
The proportioning of Ganoderma lucidum spore oil and vitamin E, be:Walnut oil 500g, spine date seed oil 100g, Boxthorn Seed Oil 100g, ganoderma lucidum spore oil
20g, vitamin E2 0g.
Embodiment 11
It is different from the proportioning for differing only in primary raw material of embodiment 9, i.e. walnut oil, spine date seed oil, Boxthorn Seed Oil, spirit
The proportioning of Ganoderma lucidum spore oil and vitamin E, be:Walnut oil 200g, spine date seed oil 300g, Boxthorn Seed Oil 40g, ganoderma lucidum spore oil 70g,
Vitamin e1 0g.
Comparative example 1
It is different from the proportioning for differing only in primary raw material of embodiment 9, i.e. walnut oil, spine date seed oil, Boxthorn Seed Oil, spirit
The proportioning of Ganoderma lucidum spore oil and vitamin E, be:Walnut oil 180g, spine date seed oil 310g, Boxthorn Seed Oil 110g, ganoderma lucidum spore oil
80g, vitamin e1 0g.
Comparative example 2
Comparative example 2 is commercially available walnut oil and Boxthorn Seed Oil in mass ratio 40:7 are made into, and manufacturing process is with comparative example 1.
Comparative example 3
Comparative example 3 is commercially available Boxthorn Seed Oil and commercially available spine date seed oil in mass ratio 7:15 are made into, the same comparative example of manufacturing process
1。
Comparative example 4
Comparative example 4 is commercially available walnut oil and commercially available ganoderma lucidum spore oil in mass ratio 8:1 is made into, and manufacturing process is with comparative example 1.
Comparative example 5
Comparative example 5 is commercially available walnut oil, Boxthorn Seed Oil and commercially available spine date seed oil in mass ratio 40:7:15 are made into, system
Make process with comparative example 1.
Comparative example 6
Comparative example 6 is commercially available walnut oil, Boxthorn Seed Oil, commercially available spine date seed oil and vitamin E in mass ratio 40:7:
15:1 is made into, and manufacturing process is with comparative example 1.
Comparative example 7
It is different from the extraction conditions for differing only in spine date seed oil of embodiment 9, with reference to patent application CN1279894A's
Embodiment 1.
The global natural perfume material Co., Ltd in commercially available walnut oil producer Jiangxi used in the comparative example of the present invention, commercially available Chinese holly
Qi Ziyou producers pray for blessings in Ningxia medlar biological Science and Technology Ltd., and commercially available ganoderma lucidum spore oil producer Guangzhou Jingjing biotechnology is limited
Company, the commercially available happy Chemical Co., Ltd.s of spine date seed oil producer Jin Jin.
Experimental example
1st, extension yellow Jackets length of one's sleep experiment
Principle:On the basis of carbrital hypnosis, whether observation tested material can extend the length of one's sleep, if the length of one's sleep
Extension, then illustrate that tested material and carbrital have synergy.
First carry out preliminary experiment before doing formal experiment, it is determined that make animal 100% fall asleep, but do not make the length of one's sleep it is long penta
Barbital sodium dosage (40mg/kg).Animal is given after physiological saline and health products given the test agent successively, 10- before peak effect occurs
15 minutes, yellow Jackets 50mg/kg is injected intraperitoneally to each group animal, using righting reflex loss as index, given the test agent is observed
Whether the yellow Jackets length of one's sleep can be extended.
Given the test agent includes embodiment 9 to 11 and comparative example 1 to 7.
As a result show, embodiment 9 to 11 can extend the yellow Jackets length of one's sleep, and with statistical significance.Wherein
The best results of embodiment 9, while comparative example 1 to 7 is not obviously prolonged the yellow Jackets length of one's sleep.Each health products are to penta bar
Than the appropriate influence for receiving the inducing mouse length of one's sleep as shown in table 1 (dosage is 40mg/kg).
Table 1
Compared with control group:**P<0.0.1。
Finally it should be noted that:Various embodiments above is merely illustrative of the technical solution of the present invention, rather than its limitations;To the greatest extent
The present invention is described in detail with reference to foregoing embodiments for pipe, it will be understood by those within the art that:Its according to
The technical scheme described in foregoing embodiments can so be modified, or which part or all technical characteristic are entered
Row equivalent substitution;And these modifications or replacement, the essence of appropriate technical solution is departed from various embodiments of the present invention technology
The scope of scheme.
Claims (10)
1. a kind of complex health care product of relieving mental strain and helping sleep, it is characterised in that be mainly made up of following component:By weight,
2. complex health care product according to claim 1, it is characterised in that by weight,
3. complex health care product according to claim 1, it is characterised in that the walnut oil contains following component:By weight
Percentage composition meter,
Unrighted acid >=93%, leukotrienes Ω 3 >=15% and leukotrienes Ω 6 >=56%;The unrighted acid includes
Leukotrienes Ω 3 and leukotrienes Ω 6;
Preferably, the walnut oil is through ultramicro grinding, CO2Supercritical extract, degumming, depickling are prepared from, the supercritical extract
The temperature that method is used is 20-40MPa for 25-35 DEG C, pressure.
4. complex health care product according to claim 1, it is characterised in that the spine date seed oil contains following component:By weight
Percentage composition meter is measured,
Total saposins >=0.42 ‰, oleic acid >=49%, linoleic acid >=26% and vitamin E >=0.27 ‰;
Preferably, the spine date seed oil is through ultramicro grinding, CO2Supercritical extract, degumming, depickling are prepared from, the overcritical extraction
It is 20-40MPa for 25-35 DEG C, pressure to follow the example of the temperature used.
5. complex health care product according to claim 1, it is characterised in that the Boxthorn Seed Oil includes following component:By weight
Percentage composition meter is measured,
Linoleic acid >=61.5%, alpha-linolenic acid >=3.1%, gamma-Linolenic acid >=3.0%, vitamin E >=0.452% and selenium >=
0.44/100000;
Preferably, the Boxthorn Seed Oil is through ultramicro grinding, CO2Supercritical extract, degumming, depickling are prepared from, the overcritical extraction
It is 20-40MPa for 25-35 DEG C, pressure to follow the example of the temperature used.
6. complex health care product according to claim 1, it is characterised in that the ganoderma lucidum spore oil includes following component:Three
Terpene aliphatic acid, unrighted acid, organic germanium and GL-B.
7. complex health care product according to claim 6, it is characterised in that the ganoderma lucidum spore oil is through ultramicro grinding, CO2It is super
Critical extraction, degumming, depickling are prepared from, and the temperature that the supercritical extraction is used is 20- for 25-35 DEG C, pressure
40MPa。
8. complex health care product according to claim 1, it is characterised in that the formulation of the complex health care product is soft capsule
Agent.
9. complex health care product according to claim 8, it is characterised in that soft capsule shell master used in the soft capsule
To be made up of following component:By weight,
200-500 parts of gelatin, preferably 400-500 parts,
150-300 parts of glycerine, preferably 150-200 parts,
250-500 parts, preferably 400-500 parts of purified water.
10. complex health care product according to claim 9, it is characterised in that the preparation method of the soft capsule shell is:First will
Glycerine, purified water mixing, add gained mixture after gelatin and are stirred 1-2 hours at 65-75 DEG C, then stand 2-3 hours, afterwards
Cast molding obtains rubber, is molded using capsule machine pelleting.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710481063.7A CN107252116A (en) | 2017-06-22 | 2017-06-22 | A kind of complex health care product of relieving mental strain and helping sleep |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710481063.7A CN107252116A (en) | 2017-06-22 | 2017-06-22 | A kind of complex health care product of relieving mental strain and helping sleep |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107252116A true CN107252116A (en) | 2017-10-17 |
Family
ID=60023342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710481063.7A Pending CN107252116A (en) | 2017-06-22 | 2017-06-22 | A kind of complex health care product of relieving mental strain and helping sleep |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107252116A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114984097A (en) * | 2022-06-14 | 2022-09-02 | 中科健康产业集团股份有限公司 | Preparation method and application of antidepressant composition |
CN116036159A (en) * | 2022-12-14 | 2023-05-02 | 南京中科药业有限公司 | A method for preparing Chinese medicinal composition extract containing Ganoderma spore oil and semen Ziziphi Spinosae oil |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101116499A (en) * | 2007-08-27 | 2008-02-06 | 宋仟惠 | Sea-buckthorn reliving imperial oil capsule |
CN102138575A (en) * | 2010-12-31 | 2011-08-03 | 颜平安 | Spina date seed/oil food with functions of tranquilizing mind, lowering lipid and preventing cancers and processing method thereof |
CN105106347A (en) * | 2015-06-26 | 2015-12-02 | 重庆医科大学 | Semen ziziphi spinosae soft capsules and preparation method thereof |
-
2017
- 2017-06-22 CN CN201710481063.7A patent/CN107252116A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101116499A (en) * | 2007-08-27 | 2008-02-06 | 宋仟惠 | Sea-buckthorn reliving imperial oil capsule |
CN102138575A (en) * | 2010-12-31 | 2011-08-03 | 颜平安 | Spina date seed/oil food with functions of tranquilizing mind, lowering lipid and preventing cancers and processing method thereof |
CN105106347A (en) * | 2015-06-26 | 2015-12-02 | 重庆医科大学 | Semen ziziphi spinosae soft capsules and preparation method thereof |
Non-Patent Citations (3)
Title |
---|
唐柳等: "灵芝孢子粉药理作用研究进展", 《天津农业科学》 * |
姜怡邓等: "枸杞籽油对小鼠耐缺氧抗疲劳作用的实验研究", 《宁夏医学院学报》 * |
李聪: "九种助眠食物让你睡得更香", 《乡村科技》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114984097A (en) * | 2022-06-14 | 2022-09-02 | 中科健康产业集团股份有限公司 | Preparation method and application of antidepressant composition |
CN116036159A (en) * | 2022-12-14 | 2023-05-02 | 南京中科药业有限公司 | A method for preparing Chinese medicinal composition extract containing Ganoderma spore oil and semen Ziziphi Spinosae oil |
CN116036159B (en) * | 2022-12-14 | 2024-02-13 | 南京中科药业有限公司 | A method for preparing Chinese medicinal composition extract containing Ganoderma spore oil and semen Ziziphi Spinosae oil |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102100273A (en) | High blood fat, high blood pressure and high blood sugar balancing tea and preparation method thereof | |
CN101513459B (en) | Chinese medicament composition for treating insomnia and preparation method thereof | |
CN107232594A (en) | A kind of complex health care product of strengthen immunity | |
CN106038670A (en) | Preparation method of Vaccinium dunalianum Wight extract | |
CN104352552A (en) | Food, health care product or medicine composition | |
CN107252116A (en) | A kind of complex health care product of relieving mental strain and helping sleep | |
CN112386589B (en) | Composition for anti-anxiety/anti-depression agent and application thereof | |
CN104666643B (en) | A kind of compound snow chrysanthemum product and its preparation method and application | |
CN113693148A (en) | Liver-nourishing eyesight-improving health tea and preparation method thereof | |
CN106963831A (en) | A kind of alternative tea of suitable hypertension and people with hyperlipidemia | |
CN103416536A (en) | Selenium-rich intestine moistening tea and production method thereof | |
CN102908396B (en) | Chinese medicinal composition for promoting sleeping and preparation method thereof | |
CN107156332A (en) | A kind of complex health care product of strengthen immunity | |
CN101433645B (en) | Chinese medicine preparation for resisting depression and stress-induced mental disorder, and preparation method thereof | |
KR101808944B1 (en) | Composition for preventing and treating dysmenorrhea and premature labor comprising non-polar solvent subfraction from Zingiber officinale extract | |
CN108433108A (en) | Six red pigment preparations of one kind and preparation method thereof | |
CN101199673A (en) | Chinese medicine compound for treating light-headedness, eyes-drying and conjunctivitis and preparing method thereof | |
CN108576309A (en) | A kind of dedicated drink and preparation method thereof refreshed oneself and relieved fatigue of emergency disaster relief personnel | |
CN111000949A (en) | Composition for improving subcutaneous fat type obesity and preparation method thereof | |
CN105287943A (en) | Compound fructus cannabis capsules, preparation method and applications thereof | |
CN101209317B (en) | Medicinal composition with sobering-up and liver-protecting action | |
CN104886574B (en) | A kind of middle-aged and old health food for improving the health care of sleep protection eyesight and preparation method thereof | |
CN107156846A (en) | Complex health care product that is a kind of antifatigue and improving anoxia endurance | |
CN109820913A (en) | The purposes and soft capsule of Zanthoxylum essential oil or Tengjiao oil | |
CN108888540A (en) | The wrinkle resistant face cream of ganoderma lucidum |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171017 |
|
RJ01 | Rejection of invention patent application after publication |